Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays
Status:
Unknown status
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
Demonstrate the therapeutic clinical equivalence of two mometasone nasal sprays in the relief
of the signs and symptoms of perennial allergic rhinitis, in term of changes at week 8 from
baseline of Total Nasal Symptom Scores (TNSS).